| Literature DB >> 34067261 |
Artak Heboyan1, Mikayel Manrikyan2, Muhammad Sohail Zafar3,4, Dinesh Rokaya5, Ruzan Nushikyan6, Izabella Vardanyan2, Anna Vardanyan1, Zohaib Khurshid7.
Abstract
The present in vivo study determined the microbiological counts of the gingival crevicular fluid (GCF) among patients with fixed dental prostheses fabricated using three different techniques. A total of 129 subjects were divided into three study groups: first, cobalt-chrome-based, metal-ceramic prostheses fabricated by the conventional method (MC, n = 35); the second group consisted of cobalt-chrome-based, metal-ceramic prostheses fabricated by the computer-aided design and computer-aided manufacturing (CAD/CAM) technique (CC-MC, n = 35); the third group comprised zirconia-based ceramic prostheses fabricated using the CAD/CAM technique (CC-Zr, n = 35). The control consisted of 24 patients using prostheses fabricated with either MC, CC-MC, or CC-Zr. The GCF was obtained from the subjects before treatment, and 6 and 12 months after the prosthetic treatment. Bacteriological and bacterioscopic analysis of the GCF was performed to analyze the patients' GCF. The data were analyzed using SPSS V20 (IBM Company, Chicago, IL, USA). The number of microorganisms of the gingival crevicular fluid in all groups at 12 months of prosthetic treatment reduced dramatically compared with the data obtained before prosthetic treatment. Inflammatory processes in the periodontium occurred slowly in the case of zirconium oxide-based ceramic constructions due to their biocompatibility with the mucous membranes and tissues of the oral cavity as well as a reduced risk of dental biofilm formation. This should be considered by dentists and prosthodontists when choosing restoration materials for subjects with periodontal pathology.Entities:
Keywords: CAD/CAM; biomaterials; crowns; dental biofilm; gingival pocket; metal-ceramic; molecular biology; oral microflora; oral microorganisms; periodontium; zirconium
Mesh:
Substances:
Year: 2021 PMID: 34067261 PMCID: PMC8196846 DOI: 10.3390/ijms22115463
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Distribution of subjects in three groups according to their periodontal status.
| Subject Details | Details |
|---|---|
| Mean age of the subjects | 34 years old (18–50) years old |
| Total Subjects/Prostheses | 129 |
| 24 | |
| 105 | |
|
MC CC-MC CC-Zr | 35 |
MC = Cobalt-chrome-based, metal-ceramic prosthesis fabricated by conventional method; CC-MC = metal-ceramic prostheses fabricated using computer-aided design and computer-aided manufacturing (CAD/CAM) technique; CC-Zr = CAD/CAM fabricated zirconia-based ceramic prostheses.
Microbiologic composition and counts of the GCF in all groups before treatment.
| Microorganism | Healthy (CFU/s) | MC (CFU/s) | CC/MC (CFU/s) | CC/Zr (CFU/s) | ||||
|---|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | |
| 6.297 × 104 | 2.037 × 105 | 1.601 × 105 | 3.554 × 105 | 1.057 × 105 | 2.724 × 105 | 2.323 × 105 | 4.261 × 105 | |
| 5.137 × 105 | 2.031 × 106 | 7.576 × 105 | 2.365 × 106 | 9.300 × 105 | 2.742 × 106 | 2.259 × 105 | 3.759 × 105 | |
| 2.597 × 104 | 4.374 × 104 | 5.369 × 104 | 1.725 × 105 | 2.253 × 105 | 3.974 × 105 | 6.241 × 105 | 2.121 × 105 | |
| 2.242 × 105 | 4.077 × 105 | 1.913 × 105 | 3.812 × 105 | 5.861 × 105 | 1.994 × 106 | 2.446 × 105 | 4.205 × 105 | |
| 1.821 × 104 | 3.749 × 104 | 1.968 × 104 | 3.791 × 104 | 6.184 × 104 | 1.994 × 104 | 2.742 × 105 | 4.548 × 105 | |
|
| 1.045 × 102 | 2.787 × 102 | 1.247 × 106 | 3.252 × 106 | 1.621 × 106 | 3.732 × 106 | 1.263 × 104 | 2.861 × 104 |
|
| 1.708 × 101 | 3.793 × 101 | 3.655 × 103 | 1.718 × 104 | 1.292 × 102 | 3.293 × 103 | 1.595 × 102 | 3.443 × 102 |
|
| 1.184 × 103 | 2.753 × 103 | 1.368 × 105 | 3.221 × 105 | 1.644 × 106 | 3.726 × 106 | 6.023 × 105 | 2.127 ×106 |
| 5.779 × 105 | 2.033 × 106 | 7.173 × 105 | 2.371 × 106 | 4.656 × 105 | 1.996 × 106 | 1.056 × 105 | 2.915 × 105 | |
| 1.630 × 104 | 3.264 × 104 | 7.884 × 104 | 2.367 × 105 | 2.533 × 105 | 4.294 × 105 | 1.068 × 104 | 2.911 ×104 | |
| 5.100 × 103 | 2.041 × 104 | 6.363 × 104 | 2.382 × 105 | 4.164 × 104 | 1.996 × 105 | 5.104 × 103 | 2.130 × 104 | |
|
| 1.054 × 103 | 2.784 × 103 | 1.352 × 104 | 2.768 × 104 | 6.376 × 103 | 1.988 × 104 | 6.161 × 105 | 2.123 × 106 |
|
| 1.058 × 103 | 2.783 × 103 | 6.662 × 103 | 1.706 × 104 | 3.120 × 103 | 4.395× 103 | 5.626 × 105 | 2.127 × 106 |
| 6.520 × 106 | 2.031 × 107 | 1.804 × 108 | 3.482 × 108 | . | . | 4.382 × 107 | 4.798 × 107 | |
Significant difference between healthy vs. CC-MC; Significant difference between healthy vs. CC-Zr; Significant difference between CC-MC vs. CC-Zr; Post hoc Scheffe. Significant at p < 0.05.
Figure 1Microorganisms observed in the GCF: Lactobacillus spp. (light microscopy, magnification × 1000, Gram stain) (A), Streptococcus spp. (light microscopy, magnification × 1000, Gram stain) (B), Fuzobacterium spp. (light microscopy, magnification × 1000, Gram stain) (C), Corynebacterium spp. (light microscopy, magnification × 1000, Gram stain) (D), Neisseria spp. (light microscopy, magnification × 1000, Gram stain) (E), Peptocococcus spp. (light microscopy, magnification × 1000, Gram stain) (F), Peptocococcus spp., Peptostreptococcus spp. (light microscopy, magnification × 1000, Gram stain) (G), Staphylococcus spp., Streptococcus spp. (light microscopy, magnification × 1000, Gram stain) (H), Fuzobacterium spp.—isolated streptococci are visible in the field of view (light microscopy, magnification × 1000, Gram stain) (I).
Microbiologic composition and counts of the GCF in all groups at six months of prosthetic treatment.
| Microorganisms | Healthy (CFU/s) | MC (CFU/s) | CC/-MC (CFU/s) | CC/Zr (CFU/s) | ||||
|---|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | |
| 4.262 × 105 | 2.039 × 103 | 1.358 × 105 | 3.225 × 105 | 2.224 × 104 | 3.986 × 104 | 1.795 × 104 | 3.367 × 104 | |
| 5.212 × 105 | 2.028 × 106 | 1.235 × 106 | 3.248 × 106 | 1.596 × 104 | 3.197 × 104 | 1.075 × 105 | 2.908 × 105 | |
| 5.502 × 104 | 2.040 × 105 | 2.413 × 104 | 4.278 × 104 | 9.488 × 103 | 2.742 × 104 | 1.519 × 104 | 3.465 × 104 | |
| 1.371 × 105 | 3.342 × 105 | 1.870 × 105 | 3.826 × 105 | 2.384 × 103 | 3.910× 103 | 1.390 × 105 | 3.502 × 105 | |
| 4.363 × 103 | 2.037 × 104 | 1.965 × 104 | 3.792 × 104 | 2.144 × 103 | 4.021 × 103 | 1.510 × 104 | 3.469 × 104 | |
|
| 9.583 × 101 | 2.804 × 102 | 1.829 × 106 | 3.846 × 106 | 1.424 × 104 | 3.255 × 104 | 1.236 × 103 | 2.873 × 103 |
|
| 2.083 × 101 | 4.148 × 101 | 6.218 × 105 | 2.385 × 106 | 4.452 × 102 | 2.001 × 103 | 1.545 × 101 | 3.460 × 101 |
|
| 6.421 × 102 | 2.033 × 103 | 1.335 × 105 | 3.226 × 105 | 4.741 × 105 | 1.994 × 106 | 2.378 × 104 | 4.240 × 104 |
| 1.980 × 104 | 3.688 × 104 | 7.319 × 104 | 2.373 × 105 | 4.893 × 104 | 2.001 × 105 | 9.278 × 104 | 2.936 × 105 | |
| 5.146 × 105 | 2.039 × 106 | 1.272 × 106 | 3.247 × 106 | 8.181 × 105 | 2.763 × 106 | 6.145 × 103 | 2.124 × 104 | |
| 9.637 × 103 | 2.803 × 104 | 1.357 × 104 | 3.225 × 104 | 1.260 × 103 | 3.300 × 103 | 2.772 × 102 | 4.534 × 102 | |
|
| 5.083 × 101 | 2.041 × 102 | 3.425 × 104 | 1.715 × 105 | 2.628 × 103 | 4.244 × 103 | 1.524 × 104 | 3.463 × 104 |
|
| 2.208 × 101 | 4.096 × 101 | 6.460 × 103 | 2.374 × 104 | 1.561 × 103 | 3.209 × 103 | 1.120 × 104 | 2.898 × 104 |
| 7.825 × 105 | 2.014 × 106 | 4.886 × 107 | 1.722 × 108 | 1.117 × 107 | 2.707 × 107 | 9.860 × 107 | 2.925 × 108 | |
|
| 0.000 | 0.000 | 4.153 × 104 | 1.724 × 105 | 5.640 × 104 | 2.001 × 105 | 5.454 × 103 | 2.132 × 104 |
Significant difference between healthy vs. CC-MC; Significant difference between MC vs. CC-MC; Post hoc Scheffe. Significant at p < 0.05.
Microbiologic composition and counts of the GCF in all groups at 12 months of treatment.
| Microorganism | Healthy (CFU/s) | MC (CFU/s) | CC/MC (CFU/s) | CC/Zr (CFU/s) | ||||
|---|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | |
| 1.291 ×102 | 3.368 × 102 | 1.651 × 104 | 3.539 × 104 | 1.496 × 103 | 3.234 × 103 | 8.422 × 103 | 2.098 × 104 | |
| 1.072 × 105 | 2.777 × 105 | 9.391 × 105 | 2.861 × 106 | 1.184 × 103 | 2.692 × 103 | 2.338 × 105 | 4.257 × 105 | |
| 4.725 × 103 | 2.039 × 104 | 1.037 × 104 | 2.852 × 104 | 9.208 × 103 | 2.745 × 104 | 2.746 × 104 | 4.546 × 104 | |
| 2.133 × 105 | 4.122 × 105 | 4.385 × 104 | 1.711 × 105 | 2.064 × 103 | 3.562 × 103 | 2.778 × 105 | 4.531 × 105 | |
| 8.041 × 101 | 2.016 × 102 | 8.541 × 103 | 2.356 × 104 | 1.736 × 102 | 3.695 × 102 | 2.327 × 103 | 4264.268 | |
|
| 1.708 × 101 | 3.793 × 101 | 2.991 × 104 | 4.595 × 104 | 2.125 × 103 | 4.031 × 103 | 5.954 × 102 | 2.129 × 103 |
|
| 5.833 × 101 | 2.041 × 102 | 3.858 × 103 | 1.722 × 104 | 1.240 × 101 | 3.307 × 101 | 0.500 × 101 | 21.325 |
|
| 1.420 × 102 | 3.333 × 102 | 4.805 × 103 | 4.978 × 103 | 1.728 × 103 | 3.698 × 103 | 5.686 × 103 | 2.126 × 104 |
| 6.105 × 104 | 2.033 × 105 | 5.426 × 103 | 1.715 × 104 | 1.296 × 103 | 3.291 × 103 | 9.604 × 102 | 2.933 × 103 | |
| 4.692 × 105 | 2.040 × 106 | 4.947 × 104 | 1.721 × 105 | 3.012 × 103 | 4.463 × 103 | 1.518 × 103 | 3.466 × 103 | |
| 5.512 × 103 | 2.040 × 104 | 1.356 × 104 | 3.226 × 104 | 4.880 × 102 | 2.001 × 103 | 0.454 × 101 | 2.132 × 101 | |
|
| 8.833 ×101 | 2.815 × 102 | 2.844 × 102 | 4.049 × 102 | 2.252 × 102 | 3.975 × 102 | 5.068 × 102 | 2.130 × 103 |
|
| 1.125 × 101 | 2.771 × 101 | 1.847 × 102 | 3.464 × 102 | 1.904 × 102 | 3.631 × 102 | 6.227 × 101 | 2.121 × 102 |
| 1.071 × 106 | 2.778 × 106 | 1.877 × 107 | 3.826 × 107 | 6.677 × 106 | 1.988 × 107 | 2.020 × 107 | 3.868 × 107 | |
|
| 0.000 | 0.000 | 3.620 × 102 | 1.719 × 103 | 1.248 × 103 | 3.304 × 103 | 4.153 × 102 | 1.923 × 103 |
Significant difference between healthy vs. CC-MC; Significant difference between MC vs. CC-MC; Significant difference between MC vs. CC-Zr; Significant difference between CC-MC vs. CC-Zr; Post hoc Scheffe. Significant at p < 0.05.